Agios Pharmaceuticals Inc

NASDAQ:AGIO   3:59:51 PM EDT
27.43
-0.88 (-3.11%)
Earnings Announcements

Agios Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 12:01 GMT
Agios Pharmaceuticals Inc (AGIO) - Agios Reports Business Highlights and Second Quarter 2022 Financial Results.
$1.1 Billion of Cash, Cash Equivalents and Marketable Securities As of June 30, 2022.
Qtrly Loss per Share $1.68.
Q2 Earnings per Share View $-1.75 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $5.89 Million
Adjusted EPS is expected to be -$1.70

Next Quarter Revenue Guidance is expected to be $8.72 Million
Next Quarter EPS Guidance is expected to be -$1.67

More details on our Analysts Page.